<p>The present invention provides a novel fusion polypeptide containing a catalytic domain of NPP1 fused to a targeting moiety, nucleic acids encoding the fusion polypeptide, a vector containing the nucleic acid integrated thereinto, a host cell transformed with the vector and pharmaceutical compositions comprising the fusion polypeptide.</p>
申请公布号
WO2012125182(A1)
申请公布日期
2012.09.20
申请号
WO2011US51858
申请日期
2011.09.15
申请人
SYNAGEVA BIOPHARMA CORP;QUINN, ANTHONY;HARVEY, ALEX J.;XIA, ZHINAN